Pedro Faísca
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Veterinary Oncology Research 12
- Co-authors
- Daniël Desmecht (6 shared papers)Catarina Pinto Reis (17 shared papers)Maria Manuela Gaspar (16 shared papers)José Catarino (15 shared papers)Lia Ascensão (7 shared papers)João M. P. Coelho (8 shared papers)Hugo Alexandre Ferreira (6 shared papers)Ana S. Viana (5 shared papers)
In The Last Decade
Pedro Faísca
61 papers receiving 957 citations
Peers
Comparison fields: 5 of 120
- Pharmaceutical Science 83
- Biomaterials 113
- Immunology 179
- Infectious Diseases 111
- Microbiology 32
Countries citing papers authored by Pedro Faísca
This map shows the geographic impact of Pedro Faísca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Faísca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Faísca more than expected).
Fields of papers citing papers by Pedro Faísca
This network shows the impact of papers produced by Pedro Faísca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Faísca. The network helps show where Pedro Faísca may publish in the future.
Co-authors
The 25 scholars most cited alongside Pedro Faísca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 74 | |
| 2 | 2020 | 72 | |
| 3 | 2006 | 62 | |
| 4 | 2006 | 48 | |
| 5 | 2020 | 43 | |
| 6 | 2019 | 42 | |
| 7 | 2005 | 35 | |
| 8 | 2010 | 35 | |
| 9 | 2023 | 29 | |
| 10 | 2022 | 27 | |
| 11 | 2021 | 26 | |
| 12 | 2019 | 25 | |
| 13 | 2020 | 23 | |
| 14 | 2021 | 22 | |
| 15 | 2017 | 21 | |
| 16 | 2020 | 20 | |
| 17 | 2005 | 20 | |
| 18 | 2022 | 19 | |
| 19 | 2016 | 19 | |
| 20 | 2012 | 18 |
About Pedro Faísca
Pedro Faísca is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology, Biomedical Engineering and Surgery, having authored 66 papers that have together received 975 indexed citations. Recurring topics across this work include Veterinary Oncology Research (12 papers), Nanoplatforms for cancer theranostics (7 papers), Gold and Silver Nanoparticles Synthesis and Applications (4 papers), Infectious Diseases and Mycology (4 papers), Salivary Gland Tumors Diagnosis and Treatment (4 papers), Respiratory viral infections research (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Advancements in Transdermal Drug Delivery (3 papers). The work is most often cited by research in Pharmaceutical Science (83 citations), Biomaterials (113 citations), Immunology (179 citations), Infectious Diseases (111 citations) and Microbiology (32 citations). Pedro Faísca has collaborated with scholars based in Portugal, Spain and Belgium. Frequent co-authors include Daniël Desmecht, Catarina Pinto Reis, Maria Manuela Gaspar, José Catarino, Lia Ascensão, João M. P. Coelho, Hugo Alexandre Ferreira, Ana S. Viana, Catarina Rosado and Philippe Gosset. Their work appears in journals such as Veterinary Sciences, Journal of Comparative Pathology, International Journal of Molecular Sciences, Molecular Metabolism and Veterinary and Comparative Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.